News Industry News Amgen's Repatha® (Evolocumab) Approved As First PCSK9 Inhibitor In Japan For The Treatment Of High Cholesterol January 21, 2016
News Industry News FDA approves Repatha to treat certain patients with high cholesterol August 28, 2015